CCM
CVS icon

Cribstone Capital Management’s CVS Health CVS Stock Holding History

Cribstone Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$589K Buy
6,318
+95
+2% +$9.17K 0.34% 70
2022
Q3 		$593K Buy
6,223
+114
+2% +$11.3K 0.37% 76
2022
Q2 		$566K Buy
6,109
+274
+5% +$26.7K 0.35% 71
2022
Q1 		$591K Sell
5,835
-2,922
-33% -$307K 0.32% 74
2021
Q4 		$903K Sell
8,757
-39
-0.4% -$3.6K 0.5% 54
2021
Q3 		$746K Sell
8,796
-137
-2% -$11.5K 0.44% 57
2021
Q2 		$745K Buy
8,933
+133
+2% +$10.9K 0.45% 57
2021
Q1 		$662K Sell
8,800
-1,697
-16% -$124K 0.44% 61
2020
Q4 		$717K Buy
10,497
+106
+1% +$6.89K 0.49% 56
2020
Q3 		$607K Buy
10,391
+945
+10% +$58.8K 0.5% 57
2020
Q2 		$614K Buy
9,446
+613
+7% +$38.6K 0.51% 59
2020
Q1 		$524K Buy
8,833
+1,540
+21% +$103K 0.55% 50
2019
Q4 		$542K Sell
7,293
-8,311
-53% -$584K 0.49% 55
2019
Q3 		$984K Sell
15,604
-1,974
-11% -$117K 0.59% 48
2019
Q2 		$958K Sell
17,578
-1,098
-6% -$59.1K 0.52% 53
2019
Q1 		$1.01M Sell
18,676
-9,852
-35% -$608K 0.53% 49
2018
Q4 		$1.87M Buy
28,528
+620
+2% +$46.3K 0.95% 33
2018
Q3 		$2.2M Buy
27,908
+638
+2% +$45.6K 1.01% 30
2018
Q2 		$1.75M Buy
27,270
+2,366
+10% +$156K 0.86% 34
2018
Q1 		$1.55M Buy
24,904
+490
+2% +$35.2K 0.76% 33
2017
Q4 		$1.77M Sell
24,414
-1,505
-6% -$109K 0.84% 33
2017
Q3 		$2.11M Buy
25,919
+821
+3% +$64.9K 1.1% 24
2017
Q2 		$2.02M Buy
25,098
+624
+3% +$49.3K 1.1% 24
2017
Q1 		$1.89M Buy
24,474
+426
+2% +$34K 1.03% 23
2016
Q4 		$1.96M Buy
24,048
+5,166
+27% +$418K 1.2% 16
2016
Q3 		$1.66M Buy
18,882
+975
+5% +$92K 1.02% 25
2016
Q2 		$1.71M Buy
17,907
+503
+3% +$50.1K 1.06% 25
2016
Q1 		$1.8M Buy
17,404
+2,173
+14% +$211K 1.45% 21
2015
Q4 		$1.48M Buy
+15,231
New +$1.49M 1.22% 25

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cribstone Capital Management's CVS Position: Q4 2022 in Review

Cribstone Capital Management increased its CVS Health (CVS) stake by 1.5% in Q4 2022, buying an estimated $9.17K and bringing the position to 6,318 shares worth $589K. The position accounts for 0.34% of the portfolio, ranked #70.

Cribstone Capital Management first reported a position in CVS in Q4 2015 and has held it in 29 quarters since. The position peaked at $2.2M in Q3 2018. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Cribstone Capital Management held 6,318 shares of CVS Health worth $589K as of Q4 2022.
  • Cribstone Capital Management bought 95 CVS Health shares in Q4 2022, an estimated $9.17K.
  • CVS Health made up 0.34% of Cribstone Capital Management's portfolio in Q4 2022, its #70 holding.
  • Cribstone Capital Management first reported a position in CVS Health in Q4 2015 and has held it in 29 quarters since.
  • Cribstone Capital Management's CVS Health position peaked at $2.2M in Q3 2018.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.